Skip to main content
Cyber Week Sale - Get 40% off Vantage
Published loading...Updated

Neflamapimod Shows Promise in Dementia With Lewy Bodies

Summary by MedPage Today
(MedPage Today) -- New data from a phase IIb trial extension study suggested that investigational neflamapimod led to significant improvements on key outcomes in people with dementia with Lewy bodies (DLB). In the RewinD-LB extension study, neflamapimod...

2 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Anti-Aging, Acupuncture and Health News broke the news in on Saturday, December 6, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal